First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies
NovalGen Ltd.
NovalGen Ltd.
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
Hrain Biotechnology Co., Ltd.
Oncotartis, Inc.
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Tianjin Ever Union Biotechnology Co., Ltd.
Cho Pharma Inc.
Xinqiao Hospital of Chongqing
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Institute for Personal Excellence, P.A.
National Cancer Institute (NCI)
National Cancer Institute (NCI)